GLP-1 RAs Hold Promising Potential for Reduction of Cardiometabolic Risk Factors additional benefits : Brain: Appetite suppression, nerve protection, and decreased neuroinflammation Heart: Decreased blood pressure (systolic and diastolic), reduced total cholesterol levels, lowered endothelial dysfunction, and increased heart rate Liver: Decreased glucose production Pancreas: Increased insulin secretion, decreased glucagon secretion, B islet cell proliferation GI Tract: Decreased gastric emptying Because these drugs cause weight loss, it is not clear whether the GLP-1 RAs or the weight loss reduces cardiometabolic risks
A trial in 32 healthy older adults reported the following findings [13]: When taken as 10mg or 25mg/daily capsules, MK-677 increased mean 24-h GH concentration by 57% and 97%, respectively
It advises only using prescription drugs, like injectable peptides, under the care of a health-care professional
doi: 10.1200/jco.23.01836
Early signs that BPC-157 is working include reduced resting pain at the injury site, improved range of motion, better post-exercise recovery, and for gut patients, reduced bloating and GI distress
Since each patient is different, theres no best option for weight loss medications